Abnormal laboratory measures (overall population) | Total population (n = 100) | SD TGC group (n = 54) | HD TGC group (n = 46) | P -value |
BUN increase, n (%) | 13 (13) | 5 (9) | 8 (17) | 0.25 |
Impaired renal function, n (%) | 19 (19) | 11 (20) | 8 (17) | 0.8 |
Impaired hepatopancreatic function,n (%) | 18 (18) | 9 (17) | 9 (19.5) | 0.9 |
Impaired hematological function, n (%) | 9 (9) | 6 (11) | 3 (6.5) | 0.5 |
Abnormal laboratory measures (VAP subgroup) | Total population (n = 63) | SD TGC group (n = 30) | HD TGC group (n = 33) | P -value |
BUN increase, n (%) | 8 (13) | 3 (10) | 5 (15) | 0.7 |
Impaired renal function, n (%) | 12 (19) | 6 (20) | 6 (18) | 1 |
Impaired hepatopancreatic function, n (%) | 11 (17.5) | 4 (13) | 7 (21) | 0.6 |
Impaired hematological function, n (%) | 4 (6) | 1 (3) | 3 (9) | 0.6 |